Eurofins Expands Its Offering in Food Testing with the Acquisition of Institut Nehring
October 16 2017 - 1:30AM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), the world leader in food testing
services announces that it has acquired Institut Nehring GmbH
(“Institut Nehring”), a leading food testing laboratory in the
German market.
Institut Nehring was established in 1905; today the company is
well-known in the German market thanks to its long-history and
excellent reputation. Institut Nehring performs a wide range of
analytical tests for all food products, including: chemical,
physical, biochemical, microbiological and sensorial testing.
Additionally, these food testing services are accompanied by food
consultancy services that cover food law, food technology, food
safety and hygiene, food quality control, site inspections and
audits, harm reports and expert counselling. To conclude this
extensive food testing and services portfolio, Institut Nehring is
a specialist in testing food contact materials especially canned
food packaging. The company has a long-standing and broad customer
base, including retailers, importers, wholesalers and producers of
food products, as well as companies and regulatory bodies operating
in the food packaging industry. The company is headquartered in
Braunschweig, Germany, employs 76 staff and generates annual
revenues close to EUR 5m.
The acquisition of Institut Nehring is an opportunity for
Eurofins to further expand its market share in the German food
testing market. The company’s broad expertise in food packaging
testing will contribute to the expansion of Eurofins’ food testing
portfolio, the most comprehensive range of state-of-the-art
analytical food testing methods in the world.
Comment from Dr. Gilles Martin, Eurofins’ CEO: “We
are pleased to welcome Institut Nehring, a highly renowned food
testing laboratory with a long history, to Eurofins’ family of
businesses. The acquisition of Institut Nehring will expand
Eurofins’ food packaging material testing services. In return,
Institut Nehring will gain access to the Group’s entire portfolio
of competencies, logistics and clients, as well as the Group’s IT
systems, which should lead to improved process optimization to the
benefit of Institut Nehring’s customers. This transaction is
another demonstration of Eurofins’ commitment to acquire advanced
technologies to expand its state-of-the-art portfolio of analytical
services.”
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter
sometimes “Eurofins” or “the Group”) believes it is the world
leader in food, environment and pharmaceutical products testing and
that it is also one of the global independent market leaders in
certain testing and laboratory services for agroscience, genomics,
discovery pharmacology and for supporting clinical studies. In
addition, Eurofins is one of the key emerging players in specialty
clinical diagnostic testing in Europe and the USA. With over 30,000
staff in 375 laboratories across 41 countries, Eurofins offers a
portfolio of over 130,000 analytical methods for evaluating the
safety, identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgment of
Eurofins Scientific’s management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171015005092/en/
Eurofins ScientificInvestor Relations+32 2 766
1620ir@eurofins.comwww.eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Sep 2023 to Sep 2024